< 1 minute read
Sep. 18, 2021

Compound 15: A Selective BACE1 Protease Inhibitor

"compound 15"

selective BACE1 protease inhibitor oral PD demonstrated on Aβ in model from optimization of prior ligand Bioorg. Med. Chem. Lett., May 1, 2020 Amgen, Thousand Oaks, CA

twitterlinkedinprintemail